CUE - Cue Biopharma EPS beats by $0.12 misses on revenue November, 17 2020 04:07 PM Cue Biopharma Inc. Cue Biopharma (CUE): Q3 GAAP EPS of -$0.34 beats by $0.12.Revenue of $0.7M (-28.6% Y/Y) misses by $1.57M.Press Release For further details see: Cue Biopharma EPS beats by $0.12, misses on revenue